AKT1 and myocardial infarction: To the best of our knowledge, this is the first study demonstrating that LA pretreatment in vivo partially preserves heart function by reducing cardiomyocyte death and inflammation secondary to MI/R, and this protection is mediated, at least in part, by PI3K/Akt activation and subsequent Nrf2 nuclear translocation.